Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile

A focused chemical optimization effort of compound 1 based on metabolite elucidation is described, resulting in 15i, a highly potent and selective mGlu5 receptor antagonist with an improved pharmacokinetic profile compared to 1. Characterization of 15i in vivo in the fear-potentiated startle (FPS) p...

Full description

Saved in:
Bibliographic Details
Published in:ACS medicinal chemistry letters 2011-01, Vol.2 (1), p.58-62
Main Authors: Carcache, David, Vranesic, Ivo, Blanz, Joachim, Desrayaud, Sandrine, Fendt, Markus, Glatthar, Ralf
Format: Article
Language:English
Subjects:
Letter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a405t-fd355f6bb8fe72b6a332a6c1a50779111ff6d0a56b63079c0a43ed7c66e116423
cites cdi_FETCH-LOGICAL-a405t-fd355f6bb8fe72b6a332a6c1a50779111ff6d0a56b63079c0a43ed7c66e116423
container_end_page 62
container_issue 1
container_start_page 58
container_title ACS medicinal chemistry letters
container_volume 2
creator Carcache, David
Vranesic, Ivo
Blanz, Joachim
Desrayaud, Sandrine
Fendt, Markus
Glatthar, Ralf
description A focused chemical optimization effort of compound 1 based on metabolite elucidation is described, resulting in 15i, a highly potent and selective mGlu5 receptor antagonist with an improved pharmacokinetic profile compared to 1. Characterization of 15i in vivo in the fear-potentiated startle (FPS) paradigm revealed a robust reduction of conditioned fear behavior. This effect nicely correlates with the rat brain pharmacokinetics.
doi_str_mv 10.1021/ml100215b
format article
fullrecord <record><control><sourceid>acs_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4018045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a71345301</sourcerecordid><originalsourceid>FETCH-LOGICAL-a405t-fd355f6bb8fe72b6a332a6c1a50779111ff6d0a56b63079c0a43ed7c66e116423</originalsourceid><addsrcrecordid>eNptUEFLwzAYDaK4OT34ByQXDx6qSdsk7UWYQ-dwsCF6DmmabBltU5Jusv16I9Oh4Ol98L33vu89AC4xusUoxnd1hVFAUhyBPs7TLCIZI8e_5h44836FEM0ZQ6egF6d5EBDSB-JBNTtTm1LsbKU8FB7ObaeaDoqmhDMnqmoLh7IzGwXrcbUm8FVJ1XbWwWHTiYVtjO88_DDdMijgpG6d3agSzl_g3FltKnUOTrSovLr4xgF4f3p8Gz1H09l4MhpOI5Ei0kW6TAjRtCgyrVhcUJEksaASC4IYyzHGWtMSCUILmiCWSyTSRJVMUqowpmmcDMD93rddF7UqZcgQvuetM7VwW26F4X83jVnyhd3wFOEMpSQY3OwNpLPeO6UPWoz4V8_80HPgXv0-dmD-FBsI13uCkJ6v7No1Ifs_Rp8oaoXG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile</title><source>Open Access: PubMed Central</source><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Carcache, David ; Vranesic, Ivo ; Blanz, Joachim ; Desrayaud, Sandrine ; Fendt, Markus ; Glatthar, Ralf</creator><creatorcontrib>Carcache, David ; Vranesic, Ivo ; Blanz, Joachim ; Desrayaud, Sandrine ; Fendt, Markus ; Glatthar, Ralf</creatorcontrib><description>A focused chemical optimization effort of compound 1 based on metabolite elucidation is described, resulting in 15i, a highly potent and selective mGlu5 receptor antagonist with an improved pharmacokinetic profile compared to 1. Characterization of 15i in vivo in the fear-potentiated startle (FPS) paradigm revealed a robust reduction of conditioned fear behavior. This effect nicely correlates with the rat brain pharmacokinetics.</description><identifier>ISSN: 1948-5875</identifier><identifier>EISSN: 1948-5875</identifier><identifier>DOI: 10.1021/ml100215b</identifier><identifier>PMID: 24900255</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Letter</subject><ispartof>ACS medicinal chemistry letters, 2011-01, Vol.2 (1), p.58-62</ispartof><rights>Copyright © 2010 American Chemical Society</rights><rights>Copyright © 2010 American Chemical Society 2010 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a405t-fd355f6bb8fe72b6a332a6c1a50779111ff6d0a56b63079c0a43ed7c66e116423</citedby><cites>FETCH-LOGICAL-a405t-fd355f6bb8fe72b6a332a6c1a50779111ff6d0a56b63079c0a43ed7c66e116423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018045/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018045/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24900255$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carcache, David</creatorcontrib><creatorcontrib>Vranesic, Ivo</creatorcontrib><creatorcontrib>Blanz, Joachim</creatorcontrib><creatorcontrib>Desrayaud, Sandrine</creatorcontrib><creatorcontrib>Fendt, Markus</creatorcontrib><creatorcontrib>Glatthar, Ralf</creatorcontrib><title>Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile</title><title>ACS medicinal chemistry letters</title><addtitle>ACS Med. Chem. Lett</addtitle><description>A focused chemical optimization effort of compound 1 based on metabolite elucidation is described, resulting in 15i, a highly potent and selective mGlu5 receptor antagonist with an improved pharmacokinetic profile compared to 1. Characterization of 15i in vivo in the fear-potentiated startle (FPS) paradigm revealed a robust reduction of conditioned fear behavior. This effect nicely correlates with the rat brain pharmacokinetics.</description><subject>Letter</subject><issn>1948-5875</issn><issn>1948-5875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNptUEFLwzAYDaK4OT34ByQXDx6qSdsk7UWYQ-dwsCF6DmmabBltU5Jusv16I9Oh4Ol98L33vu89AC4xusUoxnd1hVFAUhyBPs7TLCIZI8e_5h44836FEM0ZQ6egF6d5EBDSB-JBNTtTm1LsbKU8FB7ObaeaDoqmhDMnqmoLh7IzGwXrcbUm8FVJ1XbWwWHTiYVtjO88_DDdMijgpG6d3agSzl_g3FltKnUOTrSovLr4xgF4f3p8Gz1H09l4MhpOI5Ei0kW6TAjRtCgyrVhcUJEksaASC4IYyzHGWtMSCUILmiCWSyTSRJVMUqowpmmcDMD93rddF7UqZcgQvuetM7VwW26F4X83jVnyhd3wFOEMpSQY3OwNpLPeO6UPWoz4V8_80HPgXv0-dmD-FBsI13uCkJ6v7No1Ifs_Rp8oaoXG</recordid><startdate>20110113</startdate><enddate>20110113</enddate><creator>Carcache, David</creator><creator>Vranesic, Ivo</creator><creator>Blanz, Joachim</creator><creator>Desrayaud, Sandrine</creator><creator>Fendt, Markus</creator><creator>Glatthar, Ralf</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20110113</creationdate><title>Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile</title><author>Carcache, David ; Vranesic, Ivo ; Blanz, Joachim ; Desrayaud, Sandrine ; Fendt, Markus ; Glatthar, Ralf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a405t-fd355f6bb8fe72b6a332a6c1a50779111ff6d0a56b63079c0a43ed7c66e116423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carcache, David</creatorcontrib><creatorcontrib>Vranesic, Ivo</creatorcontrib><creatorcontrib>Blanz, Joachim</creatorcontrib><creatorcontrib>Desrayaud, Sandrine</creatorcontrib><creatorcontrib>Fendt, Markus</creatorcontrib><creatorcontrib>Glatthar, Ralf</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carcache, David</au><au>Vranesic, Ivo</au><au>Blanz, Joachim</au><au>Desrayaud, Sandrine</au><au>Fendt, Markus</au><au>Glatthar, Ralf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile</atitle><jtitle>ACS medicinal chemistry letters</jtitle><addtitle>ACS Med. Chem. Lett</addtitle><date>2011-01-13</date><risdate>2011</risdate><volume>2</volume><issue>1</issue><spage>58</spage><epage>62</epage><pages>58-62</pages><issn>1948-5875</issn><eissn>1948-5875</eissn><abstract>A focused chemical optimization effort of compound 1 based on metabolite elucidation is described, resulting in 15i, a highly potent and selective mGlu5 receptor antagonist with an improved pharmacokinetic profile compared to 1. Characterization of 15i in vivo in the fear-potentiated startle (FPS) paradigm revealed a robust reduction of conditioned fear behavior. This effect nicely correlates with the rat brain pharmacokinetics.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>24900255</pmid><doi>10.1021/ml100215b</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1948-5875
ispartof ACS medicinal chemistry letters, 2011-01, Vol.2 (1), p.58-62
issn 1948-5875
1948-5875
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4018045
source Open Access: PubMed Central; American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Letter
title Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A43%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Benzimidazoles%20as%20Potent%20and%20Orally%20Active%20mGlu5%20Receptor%20Antagonists%20with%20an%20Improved%20PK%20Profile&rft.jtitle=ACS%20medicinal%20chemistry%20letters&rft.au=Carcache,%20David&rft.date=2011-01-13&rft.volume=2&rft.issue=1&rft.spage=58&rft.epage=62&rft.pages=58-62&rft.issn=1948-5875&rft.eissn=1948-5875&rft_id=info:doi/10.1021/ml100215b&rft_dat=%3Cacs_pubme%3Ea71345301%3C/acs_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a405t-fd355f6bb8fe72b6a332a6c1a50779111ff6d0a56b63079c0a43ed7c66e116423%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/24900255&rfr_iscdi=true